Hitoshi Ishii

16PUBLICATIONS
27CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)PharmacogenomicsCancer geneticsBehavioural epidemiologyEpidemiological methods
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Sep 30, 2024
Quality of Life in Japanese People with Type 2 Diabetes Switching from Multiple Daily Insulin Injections to Once-Daily iGlarLixi: SIMPLIFY Japan.

Hitoshi Ishii, Hideki Kamiya, Yoko Takahashi

|May 17, 2024
Therapy-Related Satisfaction and Quality of Life for Japanese People with Diabetes Using Rapid-Acting Insulin Analogs: A Web-Based Survey.

Hitoshi Ishii, Yasutaka Maeda, Manaka Sato

|Oct 16, 2023
Treatment Satisfaction and Quality of Life with Tirzepatide Versus Dulaglutide Among Japanese Patients with Type 2 Diabetes: Exploratory Evaluation of the SURPASS J-mono Trial.

Hitoshi Ishii, Tomonori Oura, Masakazu Takeuchi

|Jul 19, 2023
Treatment Burden on Once-Weekly Omarigliptin Versus Daily Dipeptidyl Peptidase-4 Inhibitors in Patients with Type 2 Diabetes: Randomized Controlled Trial (ONWARD-DPP4 Study).

Hitoshi Ishii, Nozomu Kamei, Dai Shimono

|Apr 13, 2023
Risk of Lactic Acidosis in Hospitalized Diabetic Patients Prescribed Biguanides in Japan: A Retrospective Total-Population Cohort Study.

Takako Mohri, Sawako Okamoto, Yuichi Nishioka

Pageof 3